BioReNuva

What BioReNuva does

BioReNuva is a privately held biotechnology company founded in 2022 and headquartered in Austin, Texas. The company develops and supplies glycolipid biosurfactants — rhamnolipids and sophorolipids — produced through proprietary microbial fermentation that combines sugars with cosmetic oils. The core technology platform is positioned as a natural, fermentation-derived alternative to legacy petrochemical surfactants, targeting formulators who need clean-label ingredients without sacrificing functional performance such as dense foam, high clarity, strong solubilization, and improved mildness.

The commercial product portfolio consists of three branded ingredients under the ReNuva™ line: ReNuva RL-50 (a rhamnolipid described as best-in-class for foam and mildness), ReNuva SL-A70 (a medium-foam sophorolipid with documented acne and anti-inflammatory efficacy), and ReNuva SL-L70 (a low-foam sophorolipid for applications requiring minimal foaming). All three carry the INCI designation "Glycolipids" and are marketed as 100% natural. The company serves two primary customer segments: beauty and personal care brands (seeking natural anti-aging actives, biodegradable formulations, microbiome-friendly cleansing, and improved moisturization) and oral care brands (seeking mild yet effective cleansing).

BioReNuva operates a B2B ingredient supplier business model, generating revenue through one-time ingredient sales to brand formulators. Go-to-market combines direct enterprise field sales (technical consultation, sample requests) with a global distributor partner network for international supply. Marketing channels include industry trade shows (In-cosmetics Global, NYSCC Suppliers' Day, SCC chapter events), technical brochures and formulation guides, and email nurture. In March 2025, Hallstar Company's venture arm made a minority strategic investment, aligning a specialty ingredients incumbent with BioReNuva's platform. The company maintains a corporate headquarters at 801 Barton Springs Road and an R&D facility at 6101 Highland Campus Drive, both in Austin, Texas, and operates with a team of 1–10 employees.

Name

BioReNuva

Legal name

BioReNuva

Website

https://biorenuva.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

BioReNuva is an Austin-based biotech company that develops and supplies glycolipid biosurfactants (rhamnolipids and sophorolipids) produced via proprietary microbial fermentation for beauty, personal care, and oral care brand formulators seeking natural, high-performance surfactant alternatives.

Ownership category

akta.pro rank

Product category

Personal Care Ingredients

NAICS

Surface Active Agent Manufacturing (325613)

SIC

Industrial Organic Chemicals (2860)

akta.pro primary industry

Bio-based Surfactants, Detergent Ingredients & Oleochemicals (EUAAAIAE)

akta.pro secondary industry

Biochemicals & Bio-based Platform Chemicals (cellulose sugars, lignin derivatives, organic acids) (IMAMALAB)

Keywords

• Biosurfactant ingredients
• Glycolipid fermentation
• Personal care surfactants
• Rhamnolipid sophorolipid
• Cosmetic ingredient manufacturing

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Biosurfactant Ingredients Sales: Sale of glycolipid-based biosurfactant ingredients (Rhamnolipids and Sophorolipids) to beauty, personal care, and oral care brand formulators. Revenue derived from ingredient sales with consistent quality, documentation-ready materials, and commercial volume supply.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

BioReNuva engineers glycolipid biosurfactants (rhamnolipids and sophorolipids) through proprietary microbial fermentation, combining sugar with cosmetic oils to produce 100% natural, high-performance surfactants. The company sells these branded ingredients (ReNuva RL-50, SL-A70, SL-L70) to formulators in the beauty, personal care, and oral care industries as drop-in replacements for legacy petrochemical surfactants.

Product overview

BioReNuva is a biotech company that engineers 100% natural glycolipid biosurfactants produced through fermentation. The product portfolio consists of three branded ingredients: ReNuva RL-50 (rhamnolipid), ReNuva SL-A70 (medium foam sophorolipid), and ReNuva SL-L70 (low foam sophorolipid). These glycolipids are sold as ingredients to formulators in the beauty, personal care, and oral care markets, and are designed to replace legacy petrochemical surfactants while delivering functional performance including dense foam, high clarity, strong solubilization, improved mildness, and clinically supported benefits such as improved moisturization, sebum control, inflammation reduction, and microbiome-friendly cleansing.

Differentiator

Problem solved

Functional benefit

Brands

• ReNuva™: Product line of glycolipid biosurfactants including ReNuva RL-50 (Rhamnolipid), ReNuva SL-A70 (Medium Foam Sophorolipid), and ReNuva SL-L70 (Low Foam Sophorolipid) designed for beauty, personal and oral care applications.

Products and services

• ReNuva RL-50 A best-in-class rhamnolipid biosurfactant for beauty, personal care, and oral care applications. Delivers dense foam, high clarity, strong solubilization, and improved mildness as a natural alternative to petrochemical surfactants. Sold as a documented ingredient (INCI: Glycolipids) to brand formulators.
• ReNuva SL-A70 A medium-foam sophorolipid biosurfactant designed for beauty and personal care formulations. Supports acne and pore care applications with clinically tested efficacy and documented anti-inflammatory properties. Sold as a natural, INCI-designated ingredient to cosmetic formulators.
• ReNuva SL-L70 A low-foam sophorolipid biosurfactant for beauty and personal care applications where reduced foaming is desired. Offers anti-inflammatory properties and microbiome-friendly cleansing while maintaining cleaning and solubilization performance. Sold as a natural ingredient to formulators.

Quantifiable outcome

• Improved moisturization, sebum control, inflammation reduction, and microbiome-friendly cleansing compared to conventional surfactants

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators1 record

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Evonik: Global specialty chemicals major with a biotech biosurfactants portfolio including sophorolipids (e.g., REWOFERM) targeting personal care and household applications. Directly comparable as a rhamnolipid/sophorolipid supplier with far greater scale and global distribution.
• BASF Care Chemicals: World's largest chemical company and one of the largest suppliers of surfactants for personal care and home care. Comparable as a dominant incumbent that supplies both petrochemical and bio-based surfactants to global beauty brands.
• Croda International: Global specialty ingredients supplier focused on personal care, with growing portfolio of bio-based and sustainable surfactants. Comparable as a major established player in beauty/personal care specialty ingredients competing for natural formulation design-ins.
• Stepan Company: US-headquartered surfactant manufacturer producing anionic, cationic, nonionic, and amphoteric surfactants for personal care, household, and industrial markets. Comparable as an established surfactant supplier to the same downstream formulator base.
• Solvay: Global chemical company with a significant surfactants portfolio serving personal care, home care, and industrial customers. Comparable as a large incumbent offering both conventional and increasingly bio-based surfactant solutions.

Direct peers

• Holiferm: UK-based biosurfactant manufacturer producing sophorolipids and rhamnolipids via fermentation for personal care, home care, and industrial markets. Closely comparable as a fermentation-based glycolipid producer serving beauty and personal care formulators.
• Locus Performance Ingredients (Locus PI): US-based developer of fermentation-derived specialty ingredients (oligosaccharides, biosurfactants) for personal care, food, and industrial applications. Closely comparable for its microbial fermentation platform producing sustainable ingredients for beauty brands.
• AGAE Technologies: Specialty manufacturer of sophorolipid biosurfactants for personal care, household, and industrial applications. Closely comparable as a glycolipid biosurfactant producer targeting cosmetic ingredient formulators.
• Saraya Co., Ltd. Japanese company with foundational patents on sophorolipid biosurfactants and ongoing development of glycolipid products for personal care. Comparable as a pioneer and supplier of sophorolipid biosurfactants in the same target market.

Emerging players

• Glycosurf: Early-stage biosurfactant developer focused on glycolipid (sophorolipid/rhamnolipid) products from fermentation for personal care and home care. Comparable as a small, emerging glycolipid biosurfactant specialist in the same niche.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/biorenuva

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioReNuva